Minori Rosales
Technik-/Wissenschafts-/F&E-Leiter bei COMPASS THERAPEUTICS, INC.
Aktive Positionen von Minori Rosales
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
COMPASS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 | - |
Karriereverlauf von Minori Rosales
Ehemalige bekannte Positionen von Minori Rosales
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2022 | 01.05.2023 |
MACROGENICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2018 | 01.01.2022 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.10.2017 | 01.01.2018 |
Ausbildung von Minori Rosales
Yamaguchi University | Doctorate Degree |
Kansai Medical University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Japan | 3 |
Operativ
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MACROGENICS, INC. | Health Technology |
COMPASS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Börse
- Insiders
- Minori Rosales
- Erfahrung